| scholarly article | Q13442814 |
| P50 | author | Marta Carballa | Q59670476 |
| Juan Lema | Q42783263 | ||
| Francisco Omil | Q58354636 | ||
| P2093 | author name string | E Fernandez-Fontaina | |
| P2860 | cites work | Biological removal of 17α-ethinylestradiol (EE2) in an aerated nitrifying fixed bed reactor during ammonium starvation | Q60332275 |
| Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme | Q60691289 | ||
| Enhanced biodegradation of iopromide and trimethoprim in nitrifying activated sludge | Q79443735 | ||
| 2-Chlorophenol consumption and its effect on the nitrifying sludge | Q82233818 | ||
| Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway | Q83015296 | ||
| Active heterotrophic biomass and sludge retention time (SRT) as determining factors for biodegradation kinetics of pharmaceuticals in activated sludge | Q84301775 | ||
| The link between nitrification and biotransformation of 17alpha-ethinylestradiol | Q31118700 | ||
| Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies | Q33264630 | ||
| Removal of pharmaceutical residues in a pilot wastewater treatment plant | Q33268165 | ||
| Determination of pharmaceuticals, iodinated contrast media and musk fragrances in sludge by LC/tandem MS and GC/MS. | Q33433224 | ||
| Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review | Q37359484 | ||
| The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants | Q39703301 | ||
| Occurrence and fate of polycyclic musks in wastewater treatment plants in Kentucky and Georgia, USA. | Q39800102 | ||
| Removal of persistent pharmaceutical micropollutants from sewage by addition of PAC in a sequential membrane bioreactor | Q39995865 | ||
| Biodegradation of oestrogens in nitrifying activated sludge | Q42837882 | ||
| A comparison of biodegradation kinetic models applied to estrogen removal with nitrifying activated sludge. | Q42838356 | ||
| Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation | Q42932104 | ||
| Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge. | Q43022420 | ||
| Cometabolic degradation and inhibition kinetics of 1,2-dichloroethane (1,2-DCA) in suspended-growth nitrifying systems | Q43082611 | ||
| Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions | Q43118472 | ||
| Micropollutant and sludge characterization for modeling sorption equilibria | Q43200534 | ||
| The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds. | Q43307525 | ||
| Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization | Q43312193 | ||
| A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge | Q43315736 | ||
| Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment | Q43315959 | ||
| Removal of steroid estrogens in carbonaceous and nitrifying activated sludge processes | Q43319963 | ||
| Removal of pharmaceuticals and fragrances in biological wastewater treatment | Q43324764 | ||
| Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada | Q43334581 | ||
| Fate and removal of polycyclic musks, UV filters and biocides during wastewater treatment | Q43336268 | ||
| Irrigation of treated wastewater in Braunschweig, Germany: an option to remove pharmaceuticals and musk fragrances | Q43337667 | ||
| Cometabolism of trihalomethanes by mixed culture nitrifiers. | Q43339040 | ||
| Degradation of ethinyl estradiol by nitrifying activated sludge | Q43340506 | ||
| Elimination of pharmaceuticals in sewage treatment plants in Finland | Q43343588 | ||
| Elimination of beta-blockers in sewage treatment plants | Q43344336 | ||
| Calculation methods to perform mass balances of micropollutants in sewage treatment plants. application to pharmaceutical and personal care products (PPCPs). | Q43344807 | ||
| Removal of fragrance materials during U.S. and European wastewater treatment | Q43354808 | ||
| Removal of ibuprofen from wastewater: comparing biodegradation in conventional, membrane bioreactor, and biological nutrient removal treatment systems | Q43357312 | ||
| Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. | Q43366785 | ||
| Fate of beta blockers and psycho-active drugs in conventional wastewater treatment | Q43366912 | ||
| Cometabolic degradation of TCE in enriched nitrifying batch systems | Q46594854 | ||
| Determination of the solid-water distribution coefficient (Kd) for pharmaceuticals, estrogens and musk fragrances in digested sludge. | Q50943898 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biodegradation | Q696715 |
| P304 | page(s) | 5434-5444 | |
| P577 | publication date | 2012-07-28 | |
| P1433 | published in | Water Research | Q15708879 |
| P1476 | title | Influence of nitrifying conditions on the biodegradation and sorption of emerging micropollutants | |
| P478 | volume | 46 |
| Q43341606 | A comparative assessment of intensive and extensive wastewater treatment technologies for removing emerging contaminants in small communities. |
| Q89425773 | A new decentralized biological treatment process based on activated carbon targeting organic micropollutant removal from hospital wastewaters |
| Q100514335 | A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes |
| Q48216193 | Ampicillin Mineralization by Denitrifying Process: Kinetic and Metabolic Effects |
| Q36250513 | Biodegradability of fluoxetine, mefenamic acid, and metoprolol using different microbial consortiums |
| Q41978916 | Biodegradation of the artificial sweetener acesulfame in biological wastewater treatment and sandfilters. |
| Q43310796 | Biofiltration vs conventional activated sludge plants: what about priority and emerging pollutants removal? |
| Q28830523 | Biotransformation of Two Pharmaceuticals by the Ammonia-Oxidizing Archaeon Nitrososphaera gargensis |
| Q38689207 | Diffusion and sorption of organic micropollutants in biofilms with varying thicknesses |
| Q43326839 | Distribution of selected antiandrogens and pharmaceuticals in a highly impacted watershed |
| Q43337073 | Effect of advanced oxidation processes on the micropollutants and the effluent organic matter contained in municipal wastewater previously treated by three different secondary methods |
| Q47884515 | Effect of design and operational conditions on the performance of subsurface flow treatment wetlands: Emerging organic contaminants as indicators. |
| Q51472023 | Enhanced sulfamethoxazole degradation through ammonia oxidizing bacteria co-metabolism and fate of transformation products. |
| Q93346465 | Free nitrous acid (FNA) induced transformation of sulfamethoxazole in the enriched nitrifying culture |
| Q39095587 | From the conventional biological wastewater treatment to hybrid processes, the evaluation of organic micropollutant removal: A review |
| Q44775701 | Influences of solid retention time, nitrification and microbial activity on the attenuation of pharmaceuticals and estrogens in membrane bioreactors |
| Q37018650 | Investigating the removal of some pharmaceutical compounds in hospital wastewater treatment plants operating in Saudi Arabia. |
| Q51044739 | Lab-scale experimental strategy for determining micropollutant partition coefficient and biodegradation constants in activated sludge. |
| Q38377113 | Life cycle assessment and costing of urine source separation: Focus on nonsteroidal anti-inflammatory drug removal |
| Q37199367 | Metagenomic analysis of an ecological wastewater treatment plant's microbial communities and their potential to metabolize pharmaceuticals |
| Q43322050 | Modelling cometabolic biotransformation of organic micropollutants in nitrifying reactors. |
| Q50173834 | Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions-a review |
| Q38637078 | Occurrence of illicit drugs in water and wastewater and their removal during wastewater treatment |
| Q48031366 | Relative contribution of ammonia oxidizing bacteria and other members of nitrifying activated sludge communities to micropollutant biotransformation. |
| Q43326469 | Removal of PPCPs from the sludge supernatant in a one stage nitritation/anammox process. |
| Q38688101 | Removal of pharmaceuticals in pre-denitrifying MBBR - Influence of organic substrate availability in single- and three-stage configurations. |
| Q39023960 | Selective serotonin reuptake inhibitors and β-blocker transformation products may not pose a significant risk of toxicity to aquatic organisms in wastewater effluent-dominated receiving waters |
| Q27313821 | Status of hormones and painkillers in wastewater effluents across several European states-considerations for the EU watch list concerning estradiols and diclofenac |
| Q102059899 | The organic loading rate affects organic micropollutants' cometabolic biotransformation kinetics under heterotrophic conditions in activated sludge |
| Q41482324 | Tracing the limits of organic micropollutant removal in biological wastewater treatment. |
| Q57718922 | Understanding the mechanisms of trace organic contaminant removal by high retention membrane bioreactors: a critical review |
| Q89730075 | Unravelling kinetic and microbial responses of enriched nitrifying sludge under long-term exposure of cephalexin and sulfadiazine |
Search more.